Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0HCD
|
||||
| Drug Name |
2-(4-(methyl(3-(7-propyl-3-(trifluoromethyl)benzo[d]isoxazol-6-yloxy)propyl)amino)-2-(trifluoromethyl)phenyl)acetic acid
|
||||
| Synonyms |
CHEMBL382789
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H24F6N2O4
|
||||
| Canonical SMILES |
CCCc1c(OCCCN(C)c2ccc(CC(=O)O)c(c2)C(F)(F)F)ccc3c(noc13)C(F)(F)F
|
||||
| InChI |
InChI=1S/C24H24F6N2O4/c1-3-5-16-19(9-8-17-21(16)36-31-22(17)24(28,29)30)35-11-4-10-32(2)15-7-6-14(12-20(33)34)18(13-15)23(25,26)27/h6-9,13H,3-5,10-12H2,1-2H3,(H,33,34)
|
||||
| InChIKey |
XNZXFVFJRAJUDY-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Peroxisomeproliferator activated receptor delta | Target Info | [1587926] | ||
| Oxysterols receptor LXR-alpha | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Wnt signaling pathway | ||||
| WikiPathways | Wnt Signaling Pathway and Pluripotency | ||||
| Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| NRF2 pathway | |||||
| Nuclear Receptors Meta-Pathway | |||||
| Vitamin D Receptor Pathway | |||||
| Ectoderm Differentiation | |||||
| Adipogenesis | |||||
| Nuclear ReceptorsWP299:Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
| PPAR Alpha Pathway | |||||
| Liver X Receptor Pathway | |||||
| SREBF and miR33 in cholesterol and lipid homeostasis | |||||
| Nuclear Receptors | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.